Compare · HOOD vs YIN
HOOD vs YIN
Side-by-side comparison of Robinhood Markets Inc. (HOOD) and Yintech Investment Holdings Limited (YIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HOOD and YIN operate in Investment Bankers/Brokers/Service (Finance), so they compete in similar markets.
- HOOD carries a market cap of $76.58B.
- HOOD has hit the wire 24 times in the past 4 weeks while YIN has been quiet.
- HOOD has more recent analyst coverage (25 ratings vs 0 for YIN).
- Company
- Robinhood Markets Inc.
- Yintech Investment Holdings Limited
- Price
- $84.88+2.95%
- -
- Market cap
- $76.58B
- -
- 1M return
- +11.49%
- -
- 1Y return
- +15.84%
- -
- Industry
- Investment Bankers/Brokers/Service
- Investment Bankers/Brokers/Service
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2016
- News (4w)
- 24
- 0
- Recent ratings
- 25
- 0
Robinhood Markets Inc.
Robinhood Markets, Inc. operates financial services platform in the United States. Its platform allows users to invest in stocks, exchange-traded funds (ETFs), options, gold, and cryptocurrencies. The company also offers various learning and education solutions comprise Snacks, a digest of business news stories; Learn, which is a collection of approximately 650 articles, including guides, feature tutorials, and financial dictionary; Newsfeeds that offer access to free premium news from various sites, such as Barron's, Reuters, and The Wall Street Journal; and lists, which allow users to create custom watchlists to monitor securities, ETFs, and cryptocurrencies, as well as cash management services. Robinhood Markets, Inc. was incorporated in 2013 and is headquartered in Menlo Park, California.
Latest HOOD
- Chief Legal Officer Gallagher Daniel Martin Jr sold $836,771 worth of shares (10,000 units at $83.68) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 481,396 units (SEC Form 4)
- Chief Brokerage Officer Quirk Steven M. sold $931,024 worth of shares (10,837 units at $85.91) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 81,989 units (SEC Form 4)
- Director Malka Meyer converted options into 801 shares and bought $15,103,853 worth of shares (181,000 units at $83.45) (SEC Form 4)
- SEC Form 4 filed by Director Hegeman John William
- SEC Form 4 filed by Director Payne Christopher D
- SEC Form 4 filed by Director Segal Susan
- Director Zoellick Robert B. converted options into 801 shares, increasing direct ownership by 0.79% to 102,050 units (SEC Form 4)
- Director Treseder Oluwadara Johnson converted options into 801 shares, increasing direct ownership by 1% to 76,192 units (SEC Form 4)
- Director Rubinstein Jonathan converted options into 801 shares (SEC Form 4)
- Director Loop Paula converted options into 801 shares, increasing direct ownership by 1% to 72,010 units (SEC Form 4)
Latest YIN
- Yintech Announces Completion of Going Private Transaction
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Callaway Golf Company, Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited
- INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - MVC, ARA, YIN, MYOS
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited
- Departure of an Independent Director
- IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - CGIX, YIN, OTEL, BMCH
- Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)
- Lifshitz Law Firm, P.C. Announces Investigation of Pfenex Inc. (NYSE: PFNX), Proteostasis Therapeutics, Inc. (NASDAQ: PTI), Rosetta Stone Inc. (NYSE:RST) and Yintech Investment Holdings Limited (NASDAQ: YIN)
- INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – YIN, BLDR, PTI, CGIX